Skip to main content

Minimally invasive treatment of Dupuytren's contractures with Clostridium histolyticum collagenase

All patients treated for Dupuytens disease at the Regional Hospital in Horsens from 2013 to 2016 with Clostridium histolyticum collagenase with a minimum of one year follow-up were reassessed in order to determine long-term outcomes.
A 66-year-old male with needle fasciectomy of the fifth finger proximal interphalangeal (PIP) joint
A 66-year-old male with needle fasciectomy of the fifth finger proximal interphalangeal (PIP) joint

Editor

13. feb. 2019
1 min.

All patients treated for Dupuytens disease at the Regional Hospital in Horsens from 2013 to 2016 with Clostridium histolyticum collagenase with a minimum of one year follow-up were reassessed in order to determine long-term outcomes. The improvement of motion and recurrence rate differed between the metacarpophalangeal (MCP) joints and the proximal interphalangeal joints, with much better results in MCP joints.

Read original article
Clostridium histolyticum as first-line treatment of Dupuytren’s disease
Charlotte Hartig-Andreasen, Lena Schroll & Jeppe Lange